We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

IBM:NYSEInternational Business Machines Corporation analysis

Data as of Sep 16, 2026 - not real-time

Latest price
$248.37
Risk: medium
6/10Medium risk

Summary

International Business Machines Corporation is priced at $248.37 and its moving averages line up in bearish order, the shorter trailing the longer. The last 30 days have gained 9.7%. RSI sits at 60.1, which reads as approaching overbought, and MACD momentum is bullish. The recent range runs from support at $228.96 up to resistance at $251.82.
Multiples put this in fair territory: 22.1 times earnings against the sector's 32.5. The 2.71% dividend yield looks covered by current payout levels.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 29.9%, a beta of 0.89 and a maximum drawdown of 37.5%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
The horizons line up on hold — conviction 3 out of 10.

Top market events

  • IBM reports modest growth amid shifting client priorities, while focusing on AI and quantum computing investments to...
  • Morningstar%2c Inc.1monInternational Business Machines Corporation IBM Securities Investigation Notice - Levi &...
  • Yahoo Finance1monInternational Business Machines Corp IBM Q2 2026 Earnings Call Highlights: Navigating Revenue .

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 260.68
  • MACD momentum is positive

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 22.1 versus sector average of 32.5
  • Trading below the 200-day average of 260.68

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • P/E of 22.1 versus sector average of 32.5
  • Profit margin of 15.5% is healthy
  • Return on equity of 34.5%

Key metrics

Financial health

Revenue Growth1.10%
Profit Margin15.52%
P/E Ratio22.1
ROE34.46%
ROA5.30%
Debt/Equity188.97
P/B Ratio6.8
Op. Cash Flow$14.9B
Free Cash Flow$12.0B
Industry P/E32.5

Technical analysis

TrendBearish
RSI60.1
Support$228.96
Resistance$251.82
MA 20$236.10
MA 50$236.16
MA 200$260.68
MACDBullish
VolumeStable
Fear & Greed Index90.71

Valuation

Fair Value$104.65
Target Price$245.35
Upside/Downside-1.22%
GradeFair
TypeBlend
Dividend Yield2.71%

Risk assessment

Beta0.89
Volatility29.87%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.